Study of Cathepsin D Expression for Gliomas with Tissue Microarray

虞剑,张海石,陈宏,黄峰平
DOI: https://doi.org/10.3969/j.issn.1672-7770.2011.01.001
2011-01-01
Abstract:Objective To analyze the expression of cathepsin D in gliomas and its clinical meaning with high-throughput tissue microarray/tissue chip.Methods The expression of cathepsin D in the paraffin samples of 300 patients with gliomas were examined by using immunohistochemistry on tissue chip.Results In the astrocytoma specimens,the positive expression of cathepsin D is significantly different between pathological grade Ⅰ-Ⅱ(positive ratio56.84%)and Ⅲ-Ⅳ(positive ratio 81.89%),as well as the positive intensity.Positive ratio positive intensity are both significantly different between high grade astrocytomas(grade Ⅲ-Ⅳ)and normal tissue(positive ratio 31.5%).In the ependymocytoma specimens,the positive expression of cathepsin D is not significantly different between pathological grade Ⅱ and Ⅲ,but was significantly difference between tuomr and normal tissue.In the oligodendroglioma specimens,the positive expression of cathepsin D is significantly different between pathological grade Ⅱ(positive ratio 66.66%)and Ⅲ(positive ratio 86.95),as well as the positive intensity.Positive ratio positive intensity are both significantly different between oligodendrogliomas tumor tissue and that of normal(positive ratio 31.5%)(P 0.05).Conclusions The expression of cathepsin D was positively correlated with the pathological grade of astrocytomas and oligodendrogliomas.These results suggest that cathepsin D could be a potential molecular marker for high grade astrocytomas and oligodendrogliomas.
What problem does this paper attempt to address?